Waddill William D.
SEC CIK 1553338 · EDGAR
BoughtSold
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-25 16:10 | 2026-06-23 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $16.54 | +9,000 | 16.8K | +115% | +$148.9K |
| DT | 2026-06-25 16:10 | 2026-06-23 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $117.94 | -9,000 | 7,825 | -53% | -$1.06M |
| DMT | 2026-06-11 19:06 | 2026-06-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $14.96 | +9,000 | 16.8K | +115% | +$134.6K |
| DT | 2026-06-11 19:06 | 2026-06-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $107.68 | -9,000 | 7,825 | -53% | -$969.1K |
| DT | 2026-06-01 18:31 | 2026-05-29 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $11.80 | +9,000 | 16.8K | +115% | +$106.2K |
| DT | 2026-06-01 18:31 | 2026-05-29 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $99.64 | -9,000 | 7,825 | -53% | -$896.8K |
| D | 2026-02-06 | 2026-02-06 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $8.31 | +20.0K | 27.8K | +256% | +$166.2K |
| D | 2026-02-06 | 2026-02-06 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $83.68 | -20.0K | 7,825 | -72% | -$1.67M |
| D | 2026-01-06 | 2026-01-02 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | A - Grant | $0.00 | +2,695 | 7,825 | +53% | $0 |
| M | 2025-12-23 | 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | S - Sale | $67.65 | -8,367 | 56.6K | -13% | -$566.0K |
| 2025-12-18 | 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | A - Grant | $0.00 | +7,819 | 64.9K | +14% | $0 | |
| DM | 2025-10-14 | 2025-10-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $81.62 | -12.0K | 13.1K | -48% | -$979.5K |
| D | 2025-10-14 | 2025-10-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $6.98 | +12.0K | 17.1K | +234% | +$83.8K |
| 2025-09-24 | 2025-09-22 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale | $64.25 | -4,000 | 5,130 | -44% | -$257.0K | |
| 2025-08-29 | 2025-08-27 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale | $59.25 | -4,000 | 9,130 | -30% | -$237.0K | |
| 2025-03-19 | 2025-03-17 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale | $54.25 | -4,000 | 13.1K | -23% | -$217.0K | |
| D | 2025-01-06 | 2025-01-02 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | A - Grant | $0.00 | +5,130 | 17.1K | +43% | $0 |
| 2024-12-20 | 2024-12-18 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | A - Grant | $22.99 | +16.7K | 57.1K | +41% | +$384.7K | |
| M | 2024-12-18 | 2024-12-16+ | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | S - Sale | $21.97 | -7,495 | 40.4K | -16% | -$164.7K |
| D | 2024-09-12 | 2024-09-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $45.00 | -8,000 | 12.0K | -40% | -$360.0K |
| D | 2024-09-12 | 2024-09-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $12.88 | +8,000 | 20.0K | +67% | +$103.0K |
| D | 2024-07-26 | 2024-07-24 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $40.00 | -8,000 | 12.0K | -40% | -$320.0K |
| D | 2024-07-26 | 2024-07-24 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $12.88 | +8,000 | 20.0K | +67% | +$103.0K |
| D | 2024-06-11 | 2024-06-07 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $12.88 | +8,000 | 20.0K | +67% | +$103.0K |
| D | 2024-06-11 | 2024-06-07 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $35.00 | -8,000 | 12.0K | -40% | -$280.0K |
| D | 2024-03-01 | 2024-03-01 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | S - Sale+OE | $31.34 | -13.0K | 12.0K | -52% | -$406.6K |
| D | 2024-03-01 | 2024-03-01 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $6.09 | +13.0K | 25.0K | +108% | +$79.0K |
| M | 2024-01-16 | 2024-01-11 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | S - Sale | $38.07 | -3,934 | 49.2K | -7% | -$149.8K |
| 2023-12-19 | 2023-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | A - Grant | $25.41 | +15.0K | 51.8K | +41% | +$380.8K | |
| D | 2023-01-11 | 2023-01-09 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | S - Sale | $30.00 | -3,200 | 28.9K | -10% | -$96.0K |
| D | 2023-01-11 | 2023-01-10 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | A - Grant | $0.00 | +7,867 | 36.8K | +27% | $0 |
| D | 2022-05-04 | 2022-05-03 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Dir | M - OptEx | $8.59 | +12.0K | 12.0K | New | +$103.1K |
| 2022-01-07 | 2022-01-07 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | A - Grant | $0.00 | +6,400 | 32.1K | +25% | $0 | |
| M | 2022-01-04 | 2022-01-03 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Dir | S - Sale | $64.72 | -4,500 | 26.0K | -15% | -$291.2K |
Purchase Sale Sale after option exercise All abbreviations